selegiline has been researched along with Motor Neuron Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gatt, JA; Houghton, E; Kilshaw, J; Mitchell, JD; Phillips, TM; Rostron, G; Shaw, IC; Wignall, C | 1 |
| Gatt, JA; Houghton, E; Mitchell, JD; Phillips, TM; Rostron, G; Shaw, IC; Whittington, J; Wignall, C | 1 |
| Boyce, S; Carlson, E; Hill, RG; Martin, JE; Rupniak, NM; Webb, JK | 1 |
2 trial(s) available for selegiline and Motor Neuron Disease
| Article | Year |
|---|---|
Serial studies of free radical and antioxidant activity in motor neurone disease and the effect of selegiline.
Topics: Antioxidants; Cross-Over Studies; Double-Blind Method; Female; Free Radicals; Humans; Male; Motor Neuron Disease; Neuroprotective Agents; Pilot Projects; Selegiline | 1995 |
Cu/Zn superoxide dismutase free radicals, and motoneuron disease.
Topics: Ceruloplasmin; Double-Blind Method; Free Radicals; Glutathione; Glutathione Peroxidase; Humans; Motor Neuron Disease; Placebos; Selegiline; Superoxide Dismutase; Vitamin E | 1993 |
1 other study(ies) available for selegiline and Motor Neuron Disease
| Article | Year |
|---|---|
Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl.
Topics: Animals; Disease Progression; Excitatory Amino Acid Antagonists; Female; Male; Mice; Mice, Mutant Strains; Monoamine Oxidase Inhibitors; Motor Activity; Motor Neuron Disease; Nerve Degeneration; Quinolones; Selegiline; Stereoisomerism | 1999 |